Is FNCH a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Finch Therapeutics Group Inc (FNCH) is (157.65) USD. With the latest stock price at 1.80 USD, the upside of Finch Therapeutics Group Inc based on DCF is -8858.6%. This means that FNCH is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 7.8% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (304.69) - (108.48) | (157.65) |
| Upside | -17027.0% - -6126.5% | -8858.6% |